Which Is the Better High Dividend ETF, iShares' HDV or Fidelity's FDVV?

HDV (iShares Core High Dividend ETF) charges a lower expense ratio (0.08% vs 0.15%) and shows less risk with lower beta (0.53 vs 0.86) and smaller 5-year max drawdown (-15.4% vs -20.2%). Both funds deliver the same trailing 12-month dividend yield of 2.80% and similar income profiles, but FDVV’s tech-heavy tilt (about 31% tech; top weights in Nvidia 6.65%, Apple 6.05%, Microsoft 4.15%) corresponds to higher volatility and a lower defensive posture. Over the last year, FDVV slightly trails on total return (18.8% vs HDV’s 21.3%) despite higher growth of $1,000 to $1,883 vs $1,673 over 5 years, implying different return/risk tradeoffs for dividend-seeking investors.

Analysis

This is less a stock-specific catalyst than a factor wrapper decision: FDVV is effectively a backdoor quality-growth/mega-cap tech allocation with a dividend label, while HDV is a cheaper low-beta defensive basket. In a risk-off or late-cycle tape, HDV should attract flows from investors who want yield without taking implicit duration/valuation risk in NVDA/AAPL/MSFT. The second-order effect is that dividend ETF buyers may unintentionally amplify crowded positions in the same megacap names already owned through core index products.

The bigger distinction is drawdown sensitivity, not headline yield. FDVV’s higher beta makes it more vulnerable if AI leadership narrows, long rates back up, or tech multiples compress; HDV should hold up better if credit spreads widen or growth data rolls over over the next 1-3 months. Over 6-18 months, HDV also has more direct exposure to commodity/healthcare cash-flow durability, which matters if earnings breadth deteriorates.

Contrarian angle: the market may be overstating the value of FDVV’s historical excess return, because that outperformance likely came from a very narrow regime dominated by a few tech winners. If those same names simply revert to market multiples, the yield advantage is insufficient to compensate for the deeper max drawdown. Conversely, HDV’s lower fee is not the thesis; the thesis is that investors are underpricing the benefit of lower factor volatility in a tape where passive tech ownership is already heavy.

Net: this is an allocation preference, not a high-conviction trade idea unless rates or growth data force a factor rotation. The cleanest expression is relative value between low-beta dividend and tech-heavy dividend exposure, not an outright directional bet on either ETF.

Key Decisions for Investors

• Prefer HDV over FDVV for new dividend allocations over the next 1-3 months if the desk wants lower beta and less hidden tech exposure; the payoff is modestly lower upside but materially better drawdown control.
• Pair trade: long HDV / short FDVV as a factor-rotation expression if 10-year real yields rise or mega-cap tech weakens; target is outperformance in a risk-off tape, with the trade invalidated if NVDA/AAPL/MSFT leadership broadens again.
• If the goal is tech exposure rather than income, avoid FDVV and own QQQ or the specific megacaps directly; FDVV’s dividend screen dilutes upside and can lag in a sharp AI-led rerating.
• Use HDV as a defensive sleeve around earnings season or credit-spread widening; monitor whether XOM/CVX/ABBV relative strength offsets any weakness in consumer/healthcare defensives.
• Watch for a regime shift in factor leadership: if FDVV underperforms HDV by more than ~5% over a quarter while rates are flat-to-up, that would confirm the market is paying too much for tech-in-dividend-wrapper exposure.